ADAMTS13 and thrombotic thrombocytopenic purpura: The main limitation of the present study was the need for more facilities to measure the level of ADAMTS13 and its inhibitor in the country, which made it impossible to diagnose TTP and TTP-like syndrome based on ADAMTS 13 levels.